Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_assertion type Assertion NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_head.
- NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_assertion description "[Results from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_provenance.
- NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_assertion evidence source_evidence_literature NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_provenance.
- NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_assertion SIO_000772 24590266 NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_provenance.
- NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_assertion wasDerivedFrom befree-20150227 NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_provenance.
- NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_assertion wasGeneratedBy ECO_0000203 NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_provenance.